You are here

Article Text

Article menu
Download PDFPDF
Letter
Mitochondrial myopathy presenting with segmental corneal oedema and retrocorneal membrane
  1. Marcus H Colyer1,
  2. Kraig S Bower2,
  3. Thomas P Ward3,
  4. Ahmad A Hidayat3,
  5. Prem S Subramanian4
  1. 1Ophthalmology Service, Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA
  2. 2Ophthalmology Service, Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA
  3. 3Armed Forces Institute of Pathology, Washington, DC, USA
  4. 4Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
  1. Correspondence to: Dr Prem S Subramanian Ophthalmology Clinic—1F, Walter Reed Army Medical Center, Washington, DC 20307, USA; prem.subramanian{at}na.amedd.army.mil

https://doi.org/10.1136/bjo.2006.101055

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Chronic progressive external ophthalmoplegia (CPEO) is a genetic disorder of mitochondrial DNA characterised by progressive ocular dysmotility and eyelid ptosis.1 Other ophthalmological manifestations of mitochondrial eye disease include optic atrophy and retinal pigmentary changes. There have also been several reports of corneal opacification associated with Kearns–Sayre syndrome and ophthalmoplegia-plus.2–5 Corneal decompensation secondary to exposure from lagophthalmos and absent Bell’s phenomenon has been reported in CPEO, but few have progressive peripheral corneal oedema.6,7 We describe a patient presenting initially with bilateral segmental corneal oedema, in whom the subsequent diagnosis of CPEO followed the corneal changes.

    Case report

    A 38-year-old black woman with a diagnosis of primary ovarian failure presented with 5 years of bilateral progressive corneal oedema. Initial visual acuity was 20/60 …

    View Full Text

    Footnotes

    • Funding: None.

    • Competing interests: None declared.

    • The opinions expressed in this abstract are solely those of the authors and do not represent the views or official policies of the United States Army or Department of Defense.